Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 Patients at 53 sites in China were randomly assigned 1:1 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results